Integrated Wealth Concepts LLC raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 88.6% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,816 shares of the semiconductor company's stock after buying an additional 3,202 shares during the period. Integrated Wealth Concepts LLC's holdings in Synopsys were worth $3,040,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of SNPS. BlackRock Inc. acquired a new position in shares of Synopsys in the second quarter worth about $7,228,099,000. State Street Corp raised its stake in Synopsys by 0.3% during the 4th quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company's stock valued at $4,128,317,000 after purchasing an additional 28,532 shares during the period. Morgan Stanley lifted its holdings in shares of Synopsys by 2.5% in the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company's stock valued at $2,148,491,000 after purchasing an additional 109,917 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Synopsys by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company's stock worth $2,017,256,000 after buying an additional 54,329 shares during the period. Finally, Van ECK Associates Corp grew its holdings in shares of Synopsys by 19.7% during the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company's stock valued at $1,542,175,000 after buying an additional 569,687 shares in the last quarter. Institutional investors own 85.47% of the company's stock.
Analyst Upgrades and Downgrades
SNPS has been the subject of several research analyst reports. Zacks Research downgraded Synopsys from a "strong-buy" rating to a "hold" rating in a research note on Friday, August 21st. BNP Paribas Exane raised their price target on shares of Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a report on Thursday, May 28th. Robert W. Baird upgraded shares of Synopsys from a "neutral" rating to an "outperform" rating and boosted their price target for the company from $558.00 to $560.00 in a report on Thursday, August 27th. Mizuho cut their price target on Synopsys from $600.00 to $550.00 and set an "outperform" rating for the company in a research note on Thursday, August 27th. Finally, Weiss Ratings lowered shares of Synopsys from a "hold (c)" rating to a "hold (c-)" rating in a research note on Friday. Thirteen equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $562.67.
Get Our Latest Analysis on SNPS
Synopsys Price Performance
Shares of SNPS opened at $397.38 on Monday. The company has a 50-day simple moving average of $407.30 and a 200-day simple moving average of $438.12. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $539.48. The firm has a market capitalization of $76.15 billion, a P/E ratio of 70.21, a P/E/G ratio of 2.18 and a beta of 1.23.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.67 by $0.24. The business had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.Synopsys's quarterly revenue was up 42.4% on a year-over-year basis. During the same period in the previous year, the business posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities research analysts expect that Synopsys, Inc. will post 10.97 earnings per share for the current year.
Insider Activity
In related news, insider Aart de Geus sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the completion of the transaction, the insider owned 120,421 shares in the company, valued at $53,197,180.96. This trade represents a 17.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 74,641 shares of company stock valued at $32,518,171. Corporate insiders own 0.56% of the company's stock.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and related services. Its products help semiconductor and electronics companies design, verify, test and manufacture integrated circuits and complex electronic systems.
The company's EDA portfolio includes tools for digital and analog design, simulation, verification, physical implementation, signoff and manufacturing preparation. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, embedded memories and security-related components, which customers can incorporate into system-on-chip designs.
Synopsys additionally offers software integrity and application security solutions that help organizations identify and manage vulnerabilities and risks in the software development lifecycle.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.